TickerFactsScreenerDevelopers

Syndax Pharmaceuticals Inc (SNDX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $10.10M2014: $10.01M2015: $23.18M2016: $23.84M2017: $35.17M2018: $33.77M2019: $24.61M2020: $115.24M2021: $221.97M2022: $74.36M2023: $295.39M2024: $154.08M2025: $134.93M$134.93M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$134.93M-12.4%
2024$154.08M-47.8%
2023$295.39M+297.3%
2022$74.36M-66.5%
2021$221.97M+92.6%
2020$115.24M+368.3%
2019$24.61M-27.1%
2018$33.77M-4.0%
2017$35.17M+47.5%
2016$23.84M+2.9%
2015$23.18M+131.6%
2014$10.01M-0.9%
2013$10.10M—